Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $89.5800 (0.89%) ($86.8900 - $93.7100) on Tue. Feb. 9, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.87% (three month average) | RSI | 39 | Latest Price | $89.5800(0.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.9% a day on average for past five trading days. | Weekly Trend | LGND declines -3.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWM(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.435% in a week (0% probabilities). VIXM(-16%) TLT(-16%) UUP(-7%) GDXJ(-5%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.435% (StdDev 2.87%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
Resistance Level | $97.8 | 5 Day Moving Average | $94.22(-4.92%) | 10 Day Moving Average | $96.6(-7.27%) | 20 Day Moving Average | $97.8(-8.4%) | To recent high | -19.9% | To recent low | 0.9% | Market Cap | $1.44b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |